View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Tara L. French Elected to BCB Bancorp, Inc. and BCB Community Bank Boa...

Tara L. French Elected to BCB Bancorp, Inc. and BCB Community Bank Boards of Directors BAYONNE, N.J., May 02, 2024 (GLOBE NEWSWIRE) -- (the “Company”), (NASDAQ: BCBP), the holding company for BCB Community Bank (the “Bank” or “BCB”), today announced the election of Tara L. French to the Board of Directors of both BCB Bancorp, Inc. and BCB Community Bank, effective immediately. Ms. French previously was an officer at Northfield Bank until her retirement in June 2023. She joined Northfield in 2017 as the Chief Administrative Officer, and she was named Chief Risk Officer in September 2020....

 PRESS RELEASE

Teladoc Health Is Providing Free Virtual Health Care Services to Oklah...

Teladoc Health Is Providing Free Virtual Health Care Services to Oklahoma Residents Impacted by Tornadoes PURCHASE, NY, May 01, 2024 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, is providing free, 24/7 general medical telehealth visits to Oklahoma residents, first responders and others directly impacted by the recent devastating tornadoes. Individuals in Oklahoma who have been displaced or who cannot access medical care as a result of the storms can seek treatment from a licensed health care professional for any non-emergency illness ...

 PRESS RELEASE

Teladoc Health Reports First Quarter 2024 Results

Teladoc Health Reports First Quarter 2024 Results PURCHASE, NY, April 25, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the three months ended March 31, 2024 (“First Quarter 2024”). Unless otherwise noted, percentage and other changes are relative to the three months ended March 31, 2023 (“First Quarter 2023”). Financial and Operational Highlights for First Quarter 2024 First Quarter 2024 revenue grows 3% year-over-year to $646.1 millionFirst Quarter 2024 net loss of $81.9 million, or $0.4...

 PRESS RELEASE

scPharmaceuticals Announces First Participant Enrolled in Pivotal Phar...

scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection FUROSCIX Auto-injector being developed as a complement to the FUROSCIX On-body Infusor Company anticipates topline data in Q3 2024, followed by a Supplemental New Drug Application (sNDA) by year-end 2024, if successful BURLINGTON, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the deli...

 PRESS RELEASE

BCB Bancorp, Inc. Earns $5.9 Million in First Quarter 2024; Reports $0...

BCB Bancorp, Inc. Earns $5.9 Million in First Quarter 2024; Reports $0.32 EPS and Declares Quarterly Cash Dividend of $0.16 Per Share BAYONNE, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- BCB Bancorp, Inc. (the “Company”), (NASDAQ: BCBP), the holding company for BCB Community Bank (the “Bank”), today reported net income of $5.9 million for the first quarter of 2024, compared to $6.1 million in the fourth quarter of 2023, and $8.1 million for the first quarter of 2023. Earnings per diluted share for the first quarter of 2024 were $0.32, compared to $0.35 in the preceding quarter and $0.46 in t...

 PRESS RELEASE

Teladoc Health Provides Updated Start Time for First Quarter 2024 Earn...

Teladoc Health Provides Updated Start Time for First Quarter 2024 Earnings Call on April 25 PURCHASE, NY, April 15, 2024 (GLOBE NEWSWIRE) -- , Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced today that the conference call to review its first quarter 2024 results, previously scheduled for 4:30 p.m. E.T. on April 25, 2024, will now start at 5:00 p.m. E.T. on that same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 901506. For international participants, please visit the...

 PRESS RELEASE

Teladoc Health to Announce First Quarter 2024 Financial Results

Teladoc Health to Announce First Quarter 2024 Financial Results PURCHASE, NY, April 12, 2024 (GLOBE NEWSWIRE) -- , Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced that it will release first quarter 2024 results on Thursday, April 25, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 901506. For international participants, please visit the...

 PRESS RELEASE

Teladoc Health Board of Directors Announces Leadership Transition

Teladoc Health Board of Directors Announces Leadership Transition Jason Gorevic to depart the company, effective immediatelyCFO Mala Murthy appointed acting chief executiveTeladoc Health reaffirms guidance PURCHASE, NY, April 05, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today announced that Jason Gorevic is departing the company, effective immediately. The Board of Directors has appointed Mala Murthy acting Chief Executive Officer while it searches for Mr. Gorevic’s permanent successor. Ms. Murthy is a seasoned industry...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: March 26, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Finan...

scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update Generated 4Q 2023 net FUROSCIX® revenue of $6.1 million, at the upper end of the range provided in January and representing sequential growth of 61% from $3.8 million in 3Q 2023 Generated full-year net FUROSCIX® revenue of $13.6 million, at the upper end of the range provided in January Ended 2023 with cash, cash equivalents and short-term investments of $76 million Company to host investor conference call and webcast today, Wednesday, March 13, at 4:30pm ET BURLINGTON...

 PRESS RELEASE

Teladoc Health to Participate in Upcoming Investor Conference

Teladoc Health to Participate in Upcoming Investor Conference PURCHASE, NY, March 08, 2024 (GLOBE NEWSWIRE) -- , Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced today that Jason Gorevic, chief executive officer, and Mala Murthy, chief financial officer, will participate in the Barclays 26th Annual Global Healthcare Conference in Miami on March 13th, 2024. A live audio webcast and replay of the presentation will be available at . About Teladoc HealthTeladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare expe...

Daniel Ives ... (+6)
  • Daniel Ives
  • John Katsingris
  • Sam Brandeis
  • Scott Devitt
  • Steven Wahrhaftig
  • Taz Koujalgi
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch